MedTrace Logo

Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)

NCT00666367 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 182

Last updated 2010-12-24

No results posted yet for this study

Summary

This project aims to explore the relationship between Vitamin D deficiency and COPD progression via a prospective randomized placebo-controlled study. For this purpose, study was powered to 120 patients hospitalized with an exacerbation of COPD randomly assigned to a monthly oral dose of Vitamin D versus placebo. Taking into account dropouts, 182 patients are randomized during the course of the study

Conditions

Interventions

DRUG

D-cure

4 ml of D-cure (SMB oral intake) in syringe Exacta-Med Oral Dispenser.

DRUG

Placebo

4 ml of Arachidis oleum raffinatum Ph. Eur. in syringe Med Oral Dispenser.

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Wim Janssens, Prof. · KU Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-06-30
Completion
2010-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666367 on ClinicalTrials.gov